English
简体中文
Total: £ 56.28
2025-02-20 | Pages: 97 | Tables: 91
The global market for American Ginseng Supplements was valued at US$ 265 million in the year 2024 and is projected to reach a revised size of US$ 377 million by 2031, growing at a CAGR of 5.2% during the forecast period.American ginseng supplement is...
2025-02-20 | Pages: 96 | Tables: 88
The global market for No-Sting Antiseptic Cleansing Spray was valued at US$ 103 million in the year 2024 and is projected to reach a revised size of US$ 146 million by 2031, growing at a CAGR of 5.1% during the forecast period.A no-sting antiseptic c...
2025-02-20 | Pages: 93 | Tables: 94
The global market for Wound Disinfectant Spray was valued at US$ 161 million in the year 2024 and is projected to reach a revised size of US$ 228 million by 2031, growing at a CAGR of 5.1% during the forecast period.A wound disinfectant spray is an e...
2025-02-20 | Pages: 104 | Tables: 107
The global market for Fatty Acid-Free Bovine Serum Albumin Lyophilized Powder was valued at US$ 244 million in the year 2024 and is projected to reach a revised size of US$ 341 million by 2031, growing at a CAGR of 4.9% during the forecast period.Fat...
2025-02-20 | Pages: 98 | Tables: 99
The global market for Protease Free Bovine Serum Albumin Lyophilized Powder was valued at US$ 215 million in the year 2024 and is projected to reach a revised size of US$ 300 million by 2031, growing at a CAGR of 4.9% during the forecast period.Prote...
2025-02-18 | Pages: 83 | Tables: 85
The global market for Chlorhexidine Gluconate Topical Cream was valued at US$ 36.7 million in the year 2024 and is projected to reach a revised size of US$ 51 million by 2031, growing at a CAGR of 4.7% during the forecast period.Chlorhexidine Glucona...
2025-02-17 | Pages: 93 | Tables: 97
The global market for Mouse IgG was valued at US$ 1816 million in the year 2024 and is projected to reach a revised size of US$ 2538 million by 2031, growing at a CAGR of 4.9% during the forecast period.Mouse immunoglobulin G (IgG) is the primary typ...
2025-02-17 | Pages: 78 | Tables: 82
The global market for Human Coagulation Factor XIII was valued at US$ 89.6 million in the year 2024 and is projected to reach a revised size of US$ 123 million by 2031, growing at a CAGR of 4.6% during the forecast period.Human coagulation Factor XII...
2025-02-17 | Pages: 90 | Tables: 96
The global market for ADCC Enhanced Antibody was valued at US$ 12300 million in the year 2024 and is projected to reach a revised size of US$ 17190 million by 2031, growing at a CAGR of 4.9% during the forecast period.ADCC enhanced antibody refers to...
2025-02-17 | Pages: 89 | Tables: 90
The global market for Sodium Picosulfate Oral Drug was valued at US$ 267 million in the year 2024 and is projected to reach a revised size of US$ 354 million by 2031, growing at a CAGR of 4.1% during the forecast period.Sodium Picosulfate Oral Drug i...
2025-02-17 | Pages: 88 | Tables: 91
The global market for Non-Receptor Tyrosine Kinase Inhibitors was valued at US$ 8700 million in the year 2024 and is projected to reach a revised size of US$ 15790 million by 2031, growing at a CAGR of 8.9% during the forecast period.Non-receptor tyr...
2025-02-17 | Pages: 112 | Tables: 114
The global market for Animal Immunoglobulin G was valued at US$ 2793 million in the year 2024 and is projected to reach a revised size of US$ 3917 million by 2031, growing at a CAGR of 4.9% during the forecast period.Animal immunoglobulin G (IgG) is ...
2025-02-17 | Pages: 69 | Tables: 70
The global market for Lumateperone was valued at US$ 344 million in the year 2024 and is projected to reach a revised size of US$ 1234 million by 2031, growing at a CAGR of 22.5% during the forecast period.Lumiperone is a new antipsychotic drug that ...
2025-02-17 | Pages: 112 | Tables: 110
The global market for Animal Immunoglobulin was valued at US$ 3724 million in the year 2024 and is projected to reach a revised size of US$ 5205 million by 2031, growing at a CAGR of 4.9% during the forecast period.Animal immunoglobulins refer to the...
2025-02-17 | Pages: 65 | Tables: 66
The global market for Osteogenic Sarcoma Drug was valued at US$ 987 million in the year 2024 and is projected to reach a revised size of US$ 1307 million by 2031, growing at a CAGR of 4.1% during the forecast period.Osteogenic Sarcoma Drug (also know...
